Craig Thompson - Charles River
Staying with Charles River, the CRO has appointed the CEO of Memorial Sloan-Kettering Cancer Center, Craig Thompson, to its Board of Directors.
“Dr. Thompson's experience overseeing oncology and immunology research, and particularly his focus on translational medicine, will enhance the expertise of Charles River's Board,” said CEO James Foster.